Colorectal Cancer and PUFA

Colorectal cancer (CRC) is a significant global health issue, with diet and lifestyle being critical factors in its development and prevention. Among dietary components, polyunsaturated fatty acids (PUFAs) have been extensively studied for their role in CRC. PUFAs are classified into two main types: omega-3 and omega-6 fatty acids, which have contrasting effects on colorectal carcinogenesis.

Omega-3 PUFAs, found in fish oils (e.g., salmon, mackerel) and plant-based sources (e.g., flaxseeds, walnuts), include eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA). These fatty acids exhibit anti-inflammatory, anti-proliferative, and pro-apoptotic properties. They reduce inflammation by inhibiting pro-inflammatory mediators like prostaglandin E2 (PGE2), downregulate cyclooxygenase-2 (COX-2), and promote apoptosis in colorectal epithelial cells. Epidemiological studies suggest that higher omega-3 PUFA intake is associated with a reduced CRC risk, particularly in populations with diets rich in fish.

In contrast, omega-6 PUFAs, found in vegetable oils (e.g., soybean, sunflower) and nuts, include linoleic acid (LA) and arachidonic acid (AA). These fatty acids can promote inflammation and tumor progression by serving as precursors for pro-inflammatory mediators such as PGE2, which enhances cell proliferation, angiogenesis, and immune evasion. High omega-6 PUFA intake, especially when coupled with a high omega-6:omega-3 ratio, has been linked to an increased CRC risk.

Balancing dietary omega-3 and omega-6 PUFAs is crucial for CRC prevention. A low omega-6 to omega-3 ratio (<4:1) is recommended. Additionally, omega-3 PUFAs, particularly EPA and DHA, are being explored as chemopreventive agents, with promising results in reducing rectal polyp burden in familial adenomatous polyposis (FAP) patients.